Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachary T Herbert

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Molecular Immunology|November 28, 2021
Splicing factor SRSF1 controls distinct molecular programs in regulatory and effector T cells implicated in systemic autoimmune diseaseMichael F Cassidy, Zachary T Herbert, Vaishali R Moulton
Molecular Immunology|November 11, 2022
Splicing factor SRSF1 controls autoimmune-related molecular pathways in regulatory T cells distinct from FoxP3Michael F Cassidy, Zachary T Herbert, Vaishali R Moulton
Frontiers in Immunology|October 3, 2022
Splicing factor SRSF1 is essential for CD8 T cell function and host antigen-specific viral immunityIgnacio Juarez, Shi Su, Zachary T Herbert, et al.
Cancer Research|May 13, 2020
Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated TumorigenesisYou Feng, William J Mischler, Ashish C Gurung, et al.
Cell Reports|September 1, 2021
Intra- and extra-cellular environments contribute to the fate of HIV-1 infectionSneha Ratnapriya, Miranda Harris, Angela Chov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2025
BET Bromodomain Inhibition Reverses CDK4/6 Inhibitor Resistance in Estrogen Receptor-Positive Breast Cancer via Induction of miR-34a-5pRenyan Liu, Xin Wang, Timothy B Branigan, et al.
The Journal of Clinical Investigation|March 31, 2022
Ultrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complexKatarzyna Klonowska, Joannes M Grevelink, Krinio Giannikou, et al.
Diagnostics (Basel, Switzerland)|September 27, 2025
Optimization of DNA Fragmentation Techniques to Maximize Coverage Uniformity of Clinically Relevant Genes Using Whole Genome SequencingVanessa Process, Madana M R Ambavaram, Sameer Vasantgadkar, et al.
Frontiers in Medicine|May 25, 2023
Uncovering transcriptomic landscape alterations of CAN-2409 in <i>in vitro</i> and <i>in vivo</i> glioma modelsMarilin S Koch, Mykola Zdioruk, Michal O Nowicki, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Telomerase reactivation induces progression of mouse Braf <sup>V600E</sup> -driven thyroid cancers without telomere lengtheningIñigo Landa, Caitlin Em Thornton, Bin Xu, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Molecular Immunology|November 28, 2021
Splicing factor SRSF1 controls distinct molecular programs in regulatory and effector T cells implicated in systemic autoimmune diseaseMichael F Cassidy, Zachary T Herbert, Vaishali R Moulton
Molecular Immunology|November 11, 2022
Splicing factor SRSF1 controls autoimmune-related molecular pathways in regulatory T cells distinct from FoxP3Michael F Cassidy, Zachary T Herbert, Vaishali R Moulton
Frontiers in Immunology|October 3, 2022
Splicing factor SRSF1 is essential for CD8 T cell function and host antigen-specific viral immunityIgnacio Juarez, Shi Su, Zachary T Herbert, et al.
Cancer Research|May 13, 2020
Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated TumorigenesisYou Feng, William J Mischler, Ashish C Gurung, et al.
Cell Reports|September 1, 2021
Intra- and extra-cellular environments contribute to the fate of HIV-1 infectionSneha Ratnapriya, Miranda Harris, Angela Chov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2025
BET Bromodomain Inhibition Reverses CDK4/6 Inhibitor Resistance in Estrogen Receptor-Positive Breast Cancer via Induction of miR-34a-5pRenyan Liu, Xin Wang, Timothy B Branigan, et al.
The Journal of Clinical Investigation|March 31, 2022
Ultrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complexKatarzyna Klonowska, Joannes M Grevelink, Krinio Giannikou, et al.
Diagnostics (Basel, Switzerland)|September 27, 2025
Optimization of DNA Fragmentation Techniques to Maximize Coverage Uniformity of Clinically Relevant Genes Using Whole Genome SequencingVanessa Process, Madana M R Ambavaram, Sameer Vasantgadkar, et al.
Frontiers in Medicine|May 25, 2023
Uncovering transcriptomic landscape alterations of CAN-2409 in <i>in vitro</i> and <i>in vivo</i> glioma modelsMarilin S Koch, Mykola Zdioruk, Michal O Nowicki, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Telomerase reactivation induces progression of mouse Braf <sup>V600E</sup> -driven thyroid cancers without telomere lengtheningIñigo Landa, Caitlin Em Thornton, Bin Xu, et al.
Pageof 5